Pursuing claims-based data on what happens to patients taking their drugs, pharma companies have been striking pacts with payers and PBMs. Now, a heavyweight in the research field, IMS Health, has ...
Heidelberg Pharma: New Clinical Data on Lead ADC Candidate HDP-101 Presented at IMS 2024 Demonstrating Complete Remission in One Patient Data from the study with the lead ADC candidate, HDP-101, show ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback